A prospective evaluation of C-reactive protein in the progression of carotid artery stenosis

Journal of Vascular Surgery

Volumn 47, Issue 4, 2008, Pages 744-751

  Arthurs, Zachary M ^a   Andersen, Charles ^a   Starnes, Benjamin W ^b   Sohn, Vance Y ^a   Mullenix, Philip S ^c   Perry, Jason ^a  

^a MADIGAN ARMY MEDICAL CENTER   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c WALTER REED ARMY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN;

ADULT; ARTICLE; CAROTID ARTERY BIFURCATION; CAROTID ARTERY OBSTRUCTION; CAROTID ENDARTERECTOMY; DIABETES MELLITUS; DISEASE COURSE; FEMALE; FOLLOW UP; HUMAN; HYPERLIPIDEMIA; HYPERTENSION; KAPLAN MEIER METHOD; LOG RANK TEST; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; STROKE; UNIVARIATE ANALYSIS;

AGED; C-REACTIVE PROTEIN; CAROTID STENOSIS; DISEASE PROGRESSION; ENDARTERECTOMY, CAROTID; FEMALE; HUMANS; MALE; PROSPECTIVE STUDIES; REGRESSION ANALYSIS; STROKE;

EID: 41149128155     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2007.11.066     Document Type: Article

References (25)

1. Ridker P.M. Inflammation, atherosclerosis, and cardiovascular risk: an epidemiologic view. Blood Coagul Fibrinolysis 10 Suppl 1 (1999) S9-S12
2. Koenig W., Sund M., Frohlich M., Fischer H.G., Lowel H., Doring A., et al. C-Reactive protein, a sensitive marker of inflammation, predicts future risk of coronary heart disease in initially healthy middle-aged men: results from the MONICA (Monitoring Trends and Determinants in Cardiovascular Disease) Augsburg Cohort Study, 1984 to 1992. Circulation 99 (1999) 237-242
3. Blake G.J., and Ridker P.M. Novel clinical markers of vascular wall inflammation. Circ Res 89 (2001) 763-771
4. Blake G.J., and Ridker P.M. C-reactive protein and other inflammatory risk markers in acute coronary syndromes. J Am Coll Cardiol 41 4 Suppl S (2003) 37S-42S
5. Pearson T.A., Mensah G.A., Alexander R.W., Anderson J.L., Cannon III R.O., Criqui M., et al. Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association. Circulation 107 (2003) 499-511
6. Arroyo-Espliguero R., Avanzas P., Cosin-Sales J., Aldama G., Pizzi C., and Kaski J.C. C-reactive protein elevation and disease activity in patients with coronary artery disease. Eur Heart J 25 (2004) 401-408
7. Lombardo A., Biasucci L.M., Lanza G.A., Coli S., Silvestri P., Cianflone D., et al. Inflammation as a possible link between coronary and carotid plaque instability. Circulation 109 (2004) 3158-3163
8. Cao J.J., Thach C., Manolio T.A., Psaty B.M., Kuller L.H., Chaves P.H., et al. C-reactive protein, carotid intima-media thickness, and incidence of ischemic stroke in the elderly: the Cardiovascular Health Study. Circulation 108 (2003) 166-170
9. Tanne D., Benderly M., Goldbourt U., Haim M., Tenenbaum A., Fisman E.Z., et al. C-reactive protein as a predictor of incident ischemic stroke among patients with preexisting cardiovascular disease. Stroke 37 (2006) 1720-1724
10. Alvarez Garcia B., Ruiz C., Chacon P., Sabin J.A., and Matas M. High-sensitivity C-reactive protein in high-grade carotid stenosis: risk marker for unstable carotid plaque. J Vasc Surg 38 (2003) 1018-1024
11. Ridker P.M. High-sensitivity C-reactive protein, inflammation, and cardiovascular risk: from concept to clinical practice to clinical benefit. Am Heart J 148 1 Suppl (2004) S19-S26
12. Mullenix P.S., Steele S.R., Martin M.J., Starnes B.W., and Andersen C.A. C-reactive protein level and traditional vascular risk factors in the prediction of carotid stenosis. Arch Surg (2007) (Accepted, in press)
13. Mullenix P., Steele S., Martin M., Starnes B., and Andersen C. Comparison of C-reactive protein and low-density lipoprotein cholesterol levels in the prediction of carotid stenosis. J Am Coll Surg 194 3S (2004) S105
14. Moneta G.L., Edwards J.M., Papanicolaou G., Hatsukami T., Taylor Jr. L.M., Strandness Jr. D.E., et al. Screening for asymptomatic internal carotid artery stenosis: duplex criteria for discriminating 60% to 99% stenosis. J Vasc Surg 21 (1995) 989-994
15. Carpenter J.P., Lexa F.J., and Davis J.T. Determination of sixty percent or greater carotid artery stenosis by duplex Doppler ultrasonography. J Vasc Surg 22 (1995) 697-703 discussion 703-5
16. Mansour M.A., Littooy F.N., Watson W.C., Blumofe K.A., Heilizer T.J., Steffen G.F., et al. Outcome of moderate carotid artery stenosis in patients who are asymptomatic. J Vasc Surg 29 (1999) 217-225 discussion 225-7
17. Muluk S.C., Muluk V.S., Sugimoto H., Rhee R.Y., Trachtenberg J., Steed D.L., et al. Progression of asymptomatic carotid stenosis: a natural history study in 1004 patients. J Vasc Surg 29 (1999) 208-214 discussion 214-6
18. Blackburn R., Giral P., Bruckert E., Andre J.M., Gonbert S., Bernard M., et al. Elevated C-reactive protein constitutes an independent predictor of advanced carotid plaques in dyslipidemic subjects. Arterioscler Thromb Vasc Biol 21 (2001) 1962-1968
19. Sander D., Schulze-Horn C., Bickel H., Gnahn H., Bartels E., and Conrad B. Combined effects of hemoglobin A1c and C-reactive protein on the progression of subclinical carotid atherosclerosis: the INVADE study. Stroke 37 (2006) 351-357
20. Schillinger M., Exner M., Mlekusch W., Sabeti S., Amighi J., Nikowitsch R., et al. Inflammation and Carotid Artery--Risk for Atherosclerosis Study (ICARAS). Circulation 111 (2005) 2203-2209
21. Phan B.A., Chu B., Polissar N., Hatsukami T.S., Yuan C., and Zhao X.Q. Association of high-density lipoprotein levels and carotid atherosclerotic plaque characteristics by magnetic resonance imaging. Int J Cardiovasc Imaging 23 (2007) 337-342
22. Zhao X.Q., Yuan C., Hatsukami T.S., Frechette E.H., Kang X.J., Maravilla K.R., et al. Effects of prolonged intensive lipid-lowering therapy on the characteristics of carotid atherosclerotic plaques in vivo by MRI: a case-control study. Arterioscler Thromb Vasc Biol 21 (2001) 1623-1629
23. Albert M.A., Danielson E., Rifai N., and Ridker P.M. Effect of statin therapy on C-reactive protein levels: the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 286 (2001) 64-70
24. Blake G.J., Ridker P.M., and Kuntz K.M. Projected life-expectancy gains with statin therapy for individuals with elevated C-reactive protein levels. J Am Coll Cardiol 40 (2002) 49-55
25. Blake G.J., Ridker P.M., and Kuntz K.M. Potential cost-effectiveness of C-reactive protein screening followed by targeted statin therapy for the primary prevention of cardiovascular disease among patients without overt hyperlipidemia. Am J Med 114 (2003) 485-494